Board of Directors

Noam Shamay

The founder of OVALUM, Experienced R&D professional in the field of  medical devices, with proven ability to build a solid and successful team and years of experience managing large projects .

Eitan Finkelstein

Experienced financing Professional with over 20 years of practical experience in financial planning, owner of several companies and plants for treating special alloys and unique metals.

Arieh Ovadia

CEO of OWP accounting firm Senior CPA and expert in the field of : Auditing - Financial Statements, Internal Audit, Capital Raising, Sarbanes Oxley Consulting, Transfer Pricing, Taxes, Due Diligence, Economic Feasibility Studies, Investigative Auditing, Mediation, Preparation of Tax Reports, U.S Tax Returns, Financial Statements Preparation Business Entrepreneurship, Tax Consulting, Receiverships, Mergers and Acquisitions, R&D Finance, Project Financing - BOT/PFI, Prospectuses, Arbitration, Pre-Ruling, Stock Option Plans, Reorganization and Recovery Plans, Tax Planning, U.S Taxation, Corporate Taxation, Trusts, Risk Management,Liquidations, The Corporate Registrar - Liquidation Processes, Employee Compensation, Business Plans, Establishment of Accounting Standards.

David Ben Ami

Mr. Ben-Ami has more than 15 years of experience with activities in management, business development and corporate strategy in the life sciences industry.
Mr. Ben-Ami is currently the CEO of NVR Labs Inc., a pre-clinical stage adult stem cell company engaged in developing a composite implant for spinal cord injuries. Previously, Mr. Ben-Ami was Country Director of Boston Scientific Israel, and Director of Business Development of Teva Israel. Mr. Ben-Ami serves as a board member in Meytav Technological Incubator, winner of the 2005 outstanding incubator award, and in several other medical device companies. He received his MBA degree and BA in Economics & Management from Tel-Aviv University.

Samuel Cubac

Mr. Cubac began his career with GE as a Vice President with the Capital Funding Group in the US and after six years in that role, he moved to Israel and was hired as a Vice President of GE Equity, where he managed the Tel Aviv, Israel office of GE Equity. GE Equity chose Mr. Cubac to manage its limited partnership investment in ABS Giza GE Capital Fund II after GE Equity made a sponsoring investment in that fund. In addition, Mr. Cubac was responsible for managing GE Equity’s investment in Giza GE Venture Fund III were both global venture capital funds that invested in technology companies. Mr. Cubac served on the investment committees of both of those funds and was also part of the team at GE Equity responsible for choosing the portfolio companies of ABS Giza GE Capital Fund II and Giza GE Venture Fund III in which GE Equity would co-invest.

Eitan Machover

Eitan Machover joined the GE Corporate Audit Staff in 1989, spending three years working with various GE businesses, and later joining GE Capital Corporate Finance Group as a Valuation and Portfolio Manager. In 1994, Mr. Machover moved to Europe and held a number of business development positions with GE Capital in The UK and Israel. In 1997, he moved to GE Medical Systems in Paris as a Manager of Business Development. In this position, he initiated the GE Medical Systems acquisition activities of Healthcare Services companies and their integration into GE.  Mr. Machover served on the board of GE Medical Systems Israel, Ltd. as well as several other medical portfolio companies.  In May 1999, he was appointed National Executive for GE Corporate in Israel with responsibilities for the company’s overall operations and growth in the country.
In 2003 Eitan started Meditech Advisors, LLC with a number of GE colleagues. Meditech has been involved in advising and funding a number of Healthcare companies and are now operating as Private Equity fund under the name of Ziegler Meditech Equity Partners.